Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based

Aya Miyazaki1,2, Jun Negishi3, Yosuke Hayama3

  • 1Congenital Heart Disease Center, Tenri Hospital, 200 Mishima-cho, Tenri, Nara, 631-8552, Japan. ayamiya@pc4.so-net.ne.jp.

Heart and Vessels
|March 14, 2019
PubMed

Insights

This study introduces a new cardiac resynchronization therapy (CRT) strategy for congenital heart disease (CHD) patients, improving outcomes in those with ventricular conduction delays and heart failure.

Area of Science:

  • Cardiology
  • Medical Devices
  • Congenital Heart Disease

Background:

  • Cardiac resynchronization therapy (CRT) in congenital heart disease (CHD) requires tailored pacing strategies based on ventricular morphology.
  • Previous methods for systemic left ventricle (LV) pacing are not optimal for other ventricular morphologies.

Purpose of the Study:

  • To evaluate the effectiveness of a novel ventricular morphology-based CRT strategy in CHD patients.
  • To assess responder rates and identify reasons for non-response to CRT.

Main Methods:

  • Retrospective analysis of 27 CRT procedures in 24 CHD patients.
  • Implementation of a new CRT strategy based on ventricular morphology and dyssynchrony type (short-axis, long-axis, interventricular).
  • Lead placement guided by specific criteria for different ventricular morphologies and dyssynchrony patterns.

Main Results:

  • An overall responder rate of 63% (17/27) was observed.
  • Excluding cases with no baseline ventricular conduction delay/heart failure or non-optimal lead placement, the responder rate increased to 88% (14/16).
  • Identified reasons for non-response included non-optimal lead positions, absence of baseline conduction delay or heart failure symptoms, short follow-up, and extremely dilated systemic right ventricle (RV).

Conclusions:

  • The proposed ventricular morphology-based CRT strategy shows promise for CHD patients with systemic ventricular conduction delay and heart failure.
  • Optimized lead placement and patient selection (presence of conduction delay/heart failure) are crucial for successful CRT outcomes in CHD.
  • This tailored approach can improve CRT effectiveness in complex congenital heart conditions.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.5K
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.6K
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
8.9K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
313
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.5K
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
898